• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ASSURE-CSU 分析:慢性自发性荨麻疹中的血管性水肿漏诊率高,影响大。

Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSU.

机构信息

University of Toronto, Toronto, ON, Canada.

Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE.

出版信息

Allergy. 2018 Aug;73(8):1724-1734. doi: 10.1111/all.13430.

DOI:10.1111/all.13430
PMID:29460968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6055840/
Abstract

BACKGROUND

ASSURE-CSU revealed differences in physician and patient reporting of angioedema. This post hoc analysis was conducted to evaluate the actual rate of angioedema in the study population and explore differences between patients with and without angioedema.

METHODS

This international observational study assessed 673 patients with inadequately controlled chronic spontaneous urticaria (CSU). Physicians abstracted angioedema data from medical records, which were compared with patient-reported data. Patients in the Yes-angioedema category had angioedema reported in the medical record and a patient-reported source. For those in the No-angioedema category, angioedema was reported in neither the medical record nor a patient-reported source. Those in the Misaligned category had angioedema reported in only one source. Statistical comparisons between Yes-angioedema and No-angioedema categories were conducted for measures of CSU activity, health-related quality of life (HRQoL), productivity and healthcare resource utilization (HCRU). Regression analyses explored the relationship between Dermatology Life Quality Index (DLQI) score and angioedema, adjusting for important covariates.

RESULTS

Among evaluable patients, 259 (40.3%), 173 (26.9%) and 211 (32.8%) were in the Yes-angioedema, No-angioedema and Misaligned category, respectively. CSU activity and impact on HRQoL, productivity, and HCRU was greater for Yes-angioedema patients than No-angioedema patients. After covariate adjustment, mean DLQI score was significantly higher (indicating worse HRQoL) for patients with angioedema versus no angioedema (9.88 vs 7.27, P < .001). The Misaligned category had similar results with Yes-angioedema on all outcomes.

CONCLUSIONS

Angioedema in CSU seems to be under-reported but has significant negative impacts on HRQoL, daily activities, HCRU and work compared with no angioedema.

摘要

背景

ASSURE-CSU 研究揭示了医师报告和患者报告的血管性水肿之间的差异。本事后分析旨在评估研究人群中实际的血管性水肿发生率,并探讨有和无血管性水肿患者之间的差异。

方法

这项国际观察性研究共纳入 673 例未充分控制的慢性自发性荨麻疹(CSU)患者。医师从病历中提取血管性水肿数据,并与患者报告数据进行比较。在“有血管性水肿”类别中,病历和患者报告均报告有血管性水肿;在“无血管性水肿”类别中,病历和患者报告均未报告有血管性水肿;在“不匹配”类别中,仅在一个来源中报告有血管性水肿。对“有血管性水肿”和“无血管性水肿”类别之间的 CSU 活动度、健康相关生活质量(HRQoL)、生产力和医疗保健资源利用(HCRU)进行了统计学比较。回归分析探讨了调整重要协变量后,皮肤病生活质量指数(DLQI)评分与血管性水肿之间的关系。

结果

在可评估的患者中,259 例(40.3%)、173 例(26.9%)和 211 例(32.8%)分别归入“有血管性水肿”、“无血管性水肿”和“不匹配”类别。“有血管性水肿”患者的 CSU 活动度和对 HRQoL、生产力和 HCRU 的影响均大于“无血管性水肿”患者。在调整协变量后,有血管性水肿患者的平均 DLQI 评分显著高于无血管性水肿患者(9.88 分 vs 7.27 分,P<.001)。“不匹配”类别在所有结局上与“有血管性水肿”类别均具有相似的结果。

结论

CSU 中的血管性水肿似乎报告不足,但与无血管性水肿相比,它对 HRQoL、日常活动、HCRU 和工作具有显著的负面影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42d/6055840/55ddf36ed95b/ALL-73-1724-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42d/6055840/841452d353be/ALL-73-1724-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42d/6055840/d3ec9c7bd49f/ALL-73-1724-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42d/6055840/feec5a775c1f/ALL-73-1724-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42d/6055840/55ddf36ed95b/ALL-73-1724-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42d/6055840/841452d353be/ALL-73-1724-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42d/6055840/d3ec9c7bd49f/ALL-73-1724-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42d/6055840/feec5a775c1f/ALL-73-1724-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f42d/6055840/55ddf36ed95b/ALL-73-1724-g004.jpg

相似文献

1
Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSU.ASSURE-CSU 分析:慢性自发性荨麻疹中的血管性水肿漏诊率高,影响大。
Allergy. 2018 Aug;73(8):1724-1734. doi: 10.1111/all.13430.
2
The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU.慢性自发性荨麻疹负担沉重:ASSURE-CSU 的真实世界证据。
Allergy. 2017 Dec;72(12):2005-2016. doi: 10.1111/all.13209. Epub 2017 Jul 10.
3
The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study).慢性自发性荨麻疹的负担:法国治疗效果不佳及医疗资源利用情况(ASSURE-CSU研究)
Eur J Dermatol. 2018 Dec 1;28(6):795-802. doi: 10.1684/ejd.2018.3446.
4
The Role of Interleukin 10 and 18 in Chronic Spontaneous Urticaria Pathogenesis in the Context of Angioedema Coexistence.白细胞介素 10 和 18 在血管性水肿共存情况下慢性自发性荨麻疹发病机制中的作用。
J Interferon Cytokine Res. 2021 May;41(5):172-176. doi: 10.1089/jir.2020.0256.
5
H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.H1 抗组胺药难治性慢性自发性荨麻疹:比我们想象的更糟糕 - 多中心真实世界 AWARE 研究的初步结果。
Clin Exp Allergy. 2017 May;47(5):684-692. doi: 10.1111/cea.12900. Epub 2017 Mar 2.
6
Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria.慢性自发性荨麻疹成年患者特定疾病的生活质量损害
Korean J Intern Med. 2018 Jan;33(1):185-192. doi: 10.3904/kjim.2015.195. Epub 2016 Jun 1.
7
Validity and responsiveness of the Urticaria Activity and Impact Measure: A new patient-reported tool.荨麻疹活动和影响衡量标准的有效性和响应性:一种新的患者报告工具。
Ann Allergy Asthma Immunol. 2018 Jun;120(6):641-647. doi: 10.1016/j.anai.2018.03.012. Epub 2018 Mar 19.
8
ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria.ASSURE-CSU:一项关于有症状慢性自发性荨麻疹患者疾病负担的真实世界研究。
Clin Transl Allergy. 2015 Aug 17;5:29. doi: 10.1186/s13601-015-0072-9. eCollection 2015.
9
Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria.慢性自发性/特发性荨麻疹疾病活动分类分析。
Br J Dermatol. 2017 Oct;177(4):1093-1101. doi: 10.1111/bjd.15454. Epub 2017 Sep 24.
10
Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema.奥马珠单抗对难治性慢性特发性/自发性荨麻疹患者血管性水肿及生活质量的积极影响:根据血管性水肿的有无进行分析
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1056-1063. doi: 10.1111/jdv.14075. Epub 2017 Jan 17.

引用本文的文献

1
Clinical profile, prevalence, and burden of chronic spontaneous urticaria in the United States.美国慢性自发性荨麻疹的临床特征、患病率及负担
World Allergy Organ J. 2025 Jul 18;18(8):101081. doi: 10.1016/j.waojou.2025.101081. eCollection 2025 Aug.
2
Effect of combining histaglobulin with antihistamines in patients with chronic spontaneous urticaria in a tertiary care hospital setting- a randomized trial.在三级医疗机构中,组胺球蛋白联合抗组胺药治疗慢性自发性荨麻疹患者的效果——一项随机试验
Arch Dermatol Res. 2025 Mar 1;317(1):516. doi: 10.1007/s00403-025-04045-w.
3
Urticaria Voices: Real-World Experience of Patients Living with Chronic Spontaneous Urticaria.

本文引用的文献

1
In chronic spontaneous urticaria, high numbers of dermal endothelial cells, but not mast cells, are linked to recurrent angio-oedema.在慢性自发性荨麻疹中,大量真皮内皮细胞与复发性血管性水肿有关,而不是肥大细胞。
Clin Exp Dermatol. 2018 Mar;43(2):131-136. doi: 10.1111/ced.13254. Epub 2017 Oct 24.
2
Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria.奥马珠单抗显著改善慢性自发性荨麻疹患者的皮肤科相关生活质量。
J Eur Acad Dermatol Venereol. 2017 Oct;31(10):1715-1721. doi: 10.1111/jdv.14384. Epub 2017 Jul 19.
3
The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU.
荨麻疹之声:慢性自发性荨麻疹患者的真实世界体验
Dermatol Ther (Heidelb). 2025 Mar;15(3):747-761. doi: 10.1007/s13555-025-01348-8. Epub 2025 Feb 28.
4
Prevalence and Burden of Chronic Spontaneous Urticaria in Japan: A Cross-Sectional Study.日本慢性自发性荨麻疹的患病率及负担:一项横断面研究。
J Clin Med. 2025 Feb 11;14(4):1162. doi: 10.3390/jcm14041162.
5
Assesment of Salivary and Serum Levels of HBD2 in Patients with Chronic Angioedema.慢性血管性水肿患者唾液和血清中HBD2水平的评估。
J Clin Med. 2024 Dec 11;13(24):7552. doi: 10.3390/jcm13247552.
6
The prevelance of food allergy in patients with chronic idiopathic urticaria: a systematic review and meta-analysis.慢性特发性荨麻疹患者食物过敏的患病率:一项系统评价和荟萃分析。
Arch Dermatol Res. 2024 Dec 16;317(1):132. doi: 10.1007/s00403-024-03613-w.
7
Does angioedema in patients with chronic spontaneous urticaria impact response to omalizumab?慢性自发性荨麻疹患者的血管性水肿是否会影响对奥马珠单抗的反应?
World Allergy Organ J. 2024 Aug 5;17(8):100943. doi: 10.1016/j.waojou.2024.100943. eCollection 2024 Aug.
8
Disease Control and Treatment Satisfaction in Patients with Chronic Spontaneous Urticaria in Japan.日本慢性自发性荨麻疹患者的疾病控制与治疗满意度
J Clin Med. 2024 May 17;13(10):2967. doi: 10.3390/jcm13102967.
9
Impact of Chronic Spontaneous or Inducible Urticaria on Occupational Activity.慢性自发性或诱导性荨麻疹对职业活动的影响。
Acta Derm Venereol. 2024 Mar 29;104:adv36122. doi: 10.2340/actadv.v104.36122.
10
Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency.伴有正常C1抑制物的遗传性血管性水肿与羧肽酶N缺乏相关。
J Allergy Clin Immunol Glob. 2024 Feb 1;3(2):100223. doi: 10.1016/j.jacig.2024.100223. eCollection 2024 May.
慢性自发性荨麻疹负担沉重:ASSURE-CSU 的真实世界证据。
Allergy. 2017 Dec;72(12):2005-2016. doi: 10.1111/all.13209. Epub 2017 Jul 10.
4
Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria.与慢性自发性荨麻疹患者疾病严重程度和缓解时间相关的因素。
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):964-971. doi: 10.1111/jdv.14221. Epub 2017 Apr 4.
5
Analysis of disease activity categories in chronic spontaneous/idiopathic urticaria.慢性自发性/特发性荨麻疹疾病活动分类分析。
Br J Dermatol. 2017 Oct;177(4):1093-1101. doi: 10.1111/bjd.15454. Epub 2017 Sep 24.
6
H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.H1 抗组胺药难治性慢性自发性荨麻疹:比我们想象的更糟糕 - 多中心真实世界 AWARE 研究的初步结果。
Clin Exp Allergy. 2017 May;47(5):684-692. doi: 10.1111/cea.12900. Epub 2017 Mar 2.
7
Positive impact of omalizumab on angioedema and quality of life in patients with refractory chronic idiopathic/spontaneous urticaria: analyses according to the presence or absence of angioedema.奥马珠单抗对难治性慢性特发性/自发性荨麻疹患者血管性水肿及生活质量的积极影响:根据血管性水肿的有无进行分析
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):1056-1063. doi: 10.1111/jdv.14075. Epub 2017 Jan 17.
8
Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies.奥马珠单抗治疗慢性特发性/自发性荨麻疹关键性研究中的血管性水肿。
Ann Allergy Asthma Immunol. 2016 Oct;117(4):370-377.e1. doi: 10.1016/j.anai.2016.06.024. Epub 2016 Jul 14.
9
The Angioedema Quality of Life Questionnaire (AE-QoL) - assessment of sensitivity to change and minimal clinically important difference.血管性水肿生活质量问卷 (AE-QoL) - 评估变化的敏感性和最小临床重要差异。
Allergy. 2016 Aug;71(8):1203-9. doi: 10.1111/all.12900. Epub 2016 Jun 13.
10
Effect of omalizumab on angioedema in H1 -antihistamine-resistant chronic spontaneous urticaria patients: results from X-ACT, a randomized controlled trial.奥马珠单抗对 H1 抗组胺药耐药性慢性自发性荨麻疹患者血管性水肿的影响:X-ACT 随机对照试验的结果。
Allergy. 2016 Aug;71(8):1135-44. doi: 10.1111/all.12870. Epub 2016 Mar 31.